BDBM432187 N-(1-Benzylpiperidin-4-yl)-3-hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-::US10577360, Example 51

SMILES Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccc(O)c1

InChI Key InChIKey=DFNMBZOGVFNMTD-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 432187   

TargetMu-type opioid receptor(Human)
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432187(US10577360, Example 51 | N-(1-Benzylpiperidin-4-yl...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetVoltage-dependent calcium channel subunit alpha-2/delta-1(Human)
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432187(US10577360, Example 51 | N-(1-Benzylpiperidin-4-yl...)
Affinity DataKi:  2.75E+3nMAssay Description:Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent